Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1–2 dose-confirmation study
Titel:
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1–2 dose-confirmation study
Auteur:
Brooks, Kristina M Kiser, Jennifer J Ziemba, Lauren Ward, Shawn Rani, Yasha Cressey, Tim R Masheto, Gaerolwe R Cassim, Haseena Deville, Jaime G Ponatshego, Ponego L Patel, Faeezah Aurpibul, Linda Barnabas, Shaun L Mustich, Iris Coletti, Anne Heckman, Barbara Krotje, Chelsea Lojacono, Mark Yin, Dwight E Townley, Ellen Moye, Jack Majji, Sai Acosta, Edward P Ryan, Kevin Chandasana, Hardik Brothers, Cynthia H Buchanan, Ann M Rabie, Helena Flynn, Patricia M